These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

785 related items for PubMed ID: 18418430

  • 1. Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients.
    Perunicic-Pekovic G, Pljesa S, Rasic-Milutinovic Z, Stankovic S, Ilic M, Maletic R.
    Can J Physiol Pharmacol; 2008 Apr; 86(4):205-9. PubMed ID: 18418430
    [Abstract] [Full Text] [Related]

  • 2. [Inflammatory markers, nutritional parameters and polyunsaturated fatty acids in hemodialysis patients].
    Perunicić-Peković GB, Pljesa SI, Rasić ZR, Stanković SD, Ilić MN.
    Med Pregl; 2007 Apr; 60 Suppl 2():43-7. PubMed ID: 18928156
    [Abstract] [Full Text] [Related]

  • 3. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H, Qureshi AR, Heimbürger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B.
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [Abstract] [Full Text] [Related]

  • 4. Association between novel indices of malnutrition-inflammation complex syndrome and cardiovascular disease in hemodialysis patients.
    Terrier N, Senécal L, Dupuy AM, Jaussent I, Delcourt C, Leray H, Rafaelsen S, Bosc JY, Maurice F, Canaud B, Cristol JP.
    Hemodial Int; 2005 Apr; 9(2):159-68. PubMed ID: 16191065
    [Abstract] [Full Text] [Related]

  • 5. Is there any relationship between serum levels of interleukin-10 and atherosclerosis in hemodialysis patients?
    Seyrek N, Karayaylali I, Balal M, Paydas S, Aikimbaev K, Cetiner S, Seydaoglu G.
    Scand J Urol Nephrol; 2005 Apr; 39(5):405-9. PubMed ID: 16257843
    [Abstract] [Full Text] [Related]

  • 6. Significance of albumin and C-reactive protein variations in 300 end stage renal disease patients in Tehran University of Medical Sciences Hospitals during year 2010.
    Dashti N, Einollahi N, Nabatchian F, Moradi Sarabi M, Zarebavani M.
    Acta Med Iran; 2012 Apr; 50(3):197-202. PubMed ID: 22418989
    [Abstract] [Full Text] [Related]

  • 7. Malnutrition, inflammation, and lipids in a cohort of dialysis patients.
    Bowden RG, Wilson RL.
    Postgrad Med; 2010 May; 122(3):196-202. PubMed ID: 20463430
    [Abstract] [Full Text] [Related]

  • 8. The impact of dialysis type on biomarkers for cardiovascular diseases.
    Sahinarslan A, Güz G, Mutluay R, Okyay K, Demirtaş C, Paşaoğlu H, Yalçın R.
    Turk Kardiyol Dern Ars; 2011 Sep; 39(6):456-62. PubMed ID: 21918314
    [Abstract] [Full Text] [Related]

  • 9. What is the meaning of homocysteine in patients on dialysis?
    Silva de Almeida CC, Guerra DC, Vannucchi MT, Geleilete TJ, Vannucchi H, Chiarello PG.
    J Ren Nutr; 2011 Sep; 21(5):394-400. PubMed ID: 21439851
    [Abstract] [Full Text] [Related]

  • 10. Low total plasma homocysteine level in relation to malnutrition, inflammation, and outcome in hemodialysis patients.
    Akgul A, Bilgic A, Sezer S, Arat Z, Ozdemir FN, Haberal M.
    J Ren Nutr; 2008 Jul; 18(4):338-46. PubMed ID: 18558298
    [Abstract] [Full Text] [Related]

  • 11. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
    Panichi V, Taccola D, Rizza GM, Consani C, Migliori M, Filippi C, Paoletti S, Sidoti A, Borracelli D, Panicucci E, Giovannini L.
    J Nephrol; 2004 Jul; 17(5):715-20. PubMed ID: 15593040
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The evaluation of increase in hemodialysis frequency on C-reactive protein levels and nutritional status.
    Rashidi AA, Soleimani AR, Nikoueinejad H, Sarbolouki S.
    Acta Med Iran; 2013 Mar 16; 51(2):119-24. PubMed ID: 23585319
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
    Tarakçioğlu M, Erbağci AB, Usalan C, Deveci R, Kocabaş R.
    Mediators Inflamm; 2003 Feb 16; 12(1):15-9. PubMed ID: 12745544
    [Abstract] [Full Text] [Related]

  • 18. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
    Afzali B, Bakri RS, Bharma-Ariza P, Lumb PJ, Dalton N, Turner NC, Wierzbicki AS, Crook MA, Goldsmith DJ.
    J Nephrol; 2003 Feb 16; 16(4):540-5. PubMed ID: 14696756
    [Abstract] [Full Text] [Related]

  • 19. Effect of treatment with omega-3 fatty acids on C-reactive protein and tumor necrosis factor-alfa in hemodialysis patients.
    Tayyebi-Khosroshahi H, Houshyar J, Dehgan-Hesari R, Alikhah H, Vatankhah AM, Safaeian AR, Zonouz NR.
    Saudi J Kidney Dis Transpl; 2012 May 16; 23(3):500-6. PubMed ID: 22569435
    [Abstract] [Full Text] [Related]

  • 20. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T, Kúzniar J, Kusztal M, Kúzniar TJ, Weyde W, Kuriata-Kordek M, Klinger M.
    Nephrol Dial Transplant; 2009 Feb 16; 24(2):589-96. PubMed ID: 18775894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.